Details.
A multi-subscription study developed for pharmaceutical companies to track and evaluate communication across therapeutic areas and media. Suited to niche therapeutic areas with a reduced target population or low promotional exposure. Reviews medical visits, post-market-authorization studies, press coverage, email messages, meetings, and services such as applications, training, and websites. Typical observation periods are 8 to 12 weeks, with weekly online questionnaires and a report and PowerPoint deliverable.